Commercial Channels

The impact of the anti-vaccination lobby

February 02, 2016

Observational Research: Choosing the right research approach for the right question

February 02, 2016

Industry hit a record low number of FDA OPDP actions in 2015

February 01, 2016

Office of Prescription Drug Promotion finds little to complain about

A Conversation with Bill Roth, Blue Fin Group

February 01, 2016

CMS publishes the long-awaited AMP rule

January 30, 2016

'Average Manufacturer Price' is now a mostly settled matter

Mind your "Q"s: QPharma acquires Qforma

January 05, 2016

Combination expands breadth of commercialization and compliance services

FDA approved 45 new drugs in 2015--a new recent record

January 04, 2016

List includes 21 new orphan drugs, and of the 45, 15 are cold chain products

Dissecting the speed-to-therapy question

November 09, 2015

Are hubs a help or hindrance in getting patients on therapy?

Pediatric drug market finds its own pathway

November 05, 2015

Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation

Deloitte healthcare consumer survey: more trust in pharma; more interaction over healthcare costs

October 05, 2015

Biennial survey finds growing awareness of information options by consumers